Pfizer Asserts 2nd Lyrica Patent Against Mylan

Law360, New York (March 15, 2010, 4:16 PM EDT) -- Pfizer Inc. has filed a second patent infringement suit against Australia-based drugmaker Alphapharm Pty. Ltd. and U.S. affiliate Mylan Pharmaceuticals Inc. over their efforts to market a generic version of nerve pain drug Lyrica.

The pharmaceutical giant filed suit Friday in the U.S. District Court for the District of Delaware, where the parties are already litigating the defendants' efforts to introduce the generic. The new suit brings claims over a different patent.

According to the complaint, Alphapharm and Mylan have infringed U.S. Patent Number 6,197,819, titled...
To view the full article, register now.